
Startova Umksp. z o.o.
Other leasing of intellectual property and similar products, except copyrighted works
Overview
Startova Umk is involved in the Science4Business project, focusing on the commercialization of med-tech projects by providing grants and support to enhance technological readiness levels for innovative solutions. The company collaborates with various research institutes to develop advanced clinical translation and personalized therapies in the fields of genetics, oncology, neurobiology, and immunology. It aims to facilitate the transfer of knowledge and technology from academia to the business sector, fostering innovation in the LifeScience industry.
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2014-04-01. Active
14 1090 1506 0000 0001 3660 7839
19 1090 1506 0000 0001 2304 9186
23 1090 1506 0000 0001 3333 2666
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 19, 2024 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $163 | Prezes Zakładu Ubezpieczeń Społecznych | |
| Apr 19, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $1,178 | Prezes Banku Gospodarstwa Krajowego |
Tenders
No recorded participation in tenders.
Authorized Representatives
Manner of representation
A declaration of will on behalf of the company is made by the President of the Management Board. In the case of a multi-member management board, each member of the management board is authorised to make declarations of will on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Uniwersytet Mikołaja Kopernika W Toruniu | 10 | $28,363.05 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Michał Marek Polasik (49) | Shareholder of a limited liability company, 2000.0 PLN |
Piotr Michał Sałata (39) | Shareholder of a limited liability company, 2000.0 PLN |
Subsidiaries
| Name | Share value | Stake | |
|---|---|---|---|
Immbionicsp. z o.o. | 270.12 USD | 19.802% | |
Natchemlabsp. z o.o. | 405.19 USD | 27.2727% | |
Biosep Technologiessp. z o.o. | 324.15 USD | 24% |
Competitors
| Name | Revenue | Website | |
|---|---|---|---|
| Univentum Labssp. z o.o. | $243,765.01 | univentum.pl |
Change history
| Date | Event |
|---|---|
| 2025-06-24 | Name change (Startova.pl → Startova Umk) |
| 2025-06-24 | PKD change (Removed: 69.20.Z, 70.22.Z, 71.12.Z, 72.11.Z, 72.19.Z, 74.10.Z, 74.90.Z, 77.40.Z; Added: 69.20.A, 70.20.Z, 71.12.B, 72.10.Z, 74.12.Z, 74.91.Z, 74.99.Z, 77.40.B) |
| 2022-06-07 | Address change (Gagarina 5/102, 87-100, Toruń → Ul. Jurija Gagarina 7, 87-100, Toruń) |
| 2022-02-07 | Name change ("centrum Transferu Technologii Umk" → Startova.pl) |
| 2018-07-22 | PKD change (Removed: 71.20.A; Added: 69.20.Z) |
FAQ
Last updated: 2026-07-04
